Kingbo Strike Limited announced that Mr. Li Jin Li?) has resigned as an independent non-executive Director (?INED?), a member of each of the nomination committee (the ?Nomination Committee?), the audit committee (the ?Audit Committee?) and the remuneration committee (the ?Remuneration Committee?) of the Board with effect from 1 March 2024 to pursue his personal business. The Board is pleased to announced that: (i) Mr. Wang Haoyuan (?Mr. Wang?) has been appointed as an INED of the Company, a member of each of the Nomination Committee, the Audit Committee and the Remuneration Committee with effect from 1 March 2024; and Ms. Ye Jieting (?Ms. Ye?) has been appointed as an INED of the Company, a member of each of the Audit Committee and the Remuneration Committee with effect from 1 March 2024. Mr. Wang, aged 29, obtained a bachelor's degree in commerce from the University of Western Australia and a master's degree in investment management from the Hong Kong University of Science and Technology in 2018 and 2020 respectively.

Between April 2020 and January 2023, he worked in various private companies as research analyst, including Country Garden Venture Capital and Bear. Since March 2023, he has been working in an asset management firm which engages in private securities investment and asset management services in China. Ms. Ye, aged 50, has more than 20 years of experience in corporate management and strategic management.

She has served as the legal representative of multiple companies including Guangzhou Mingying Material Technology Ltd., Guangzhou Mingying Enterprise Management Consulting Co., Ltd, Guangdong Hejiang Smart Medical Technology Co. Ltd. and Guicheng Crystal Carved Jewelry Store, Nanhai District, Foshan City. She served as an executive director in Guangzhou Mingying Material Technology Ltd. and Guangzhou Mingying Enterprise Management Consulting Co.

Ltd. until January 2008 and October 2018 respectively. She served as an executive director and the general manager in Guangdong Hejiang Smart Medical Technology Co. Ltd. until January 2019.

She is currently a director of Guangzhou Hejiang Medical Investment Consulting Company Limited and is responsible for the strategic planning and decision making of the company. Immediately after the appointment of Mr. Wang and Ms. Ye, the composition of the Board committees is as follows: Audit Committee: Mr. Chen Yeung Tak (Chairman), Dr. Luo Xiaodong, Mr. Wang and Ms. Ye; Nomination Committee: Liu Yancheng (Chairman), Dr. Luo Xiaodong, Mr. Chen Yeung Tak, and Mr. Wang; and Remuneration Committee: Mr. Chen Yeung Tak (Chairman), Dr. Luo Xiaodong, Mr. Wang and Ms. Ye.